Indications for early aspirin use in acute ischemic stroke : A combined analysis of 40 000 randomized patients from the chinese acute stroke trial and the international stroke trial. On behalf of the CAST and IST collaborative groups.

No abstract is available for this paper.

• Publication year

  2000

• Venue

  Stroke

• Publication date

  2000-06-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1161/01.STR.31.6.1240PMID 10835439
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Aspirin and risk of hemorrhagic stroke.

  1999cited by this paper
• Aspirin and risk of hemorrhagic stroke.

  1999cited by this paper
• Clinical trials in stroke.

  1999cited by this paper
• Immediate aspirin for suspected ischaemic stroke.

  1999cited by this paper
• Antiplatelet therapy in acute cerebral ischaemia.

  1999cited by this paper
• Antiplatelet therapy in acute cerebral ischemia.

  1999cited by this paper
• Stroke treatment: time is brain.

  1998cited by this paper
• Management soon after a stroke

  1998cited by this paper
• Aspirin and risk of hemorrhagic stroke: a meta-analysis of randomized controlled trials.

  1998cited by this paper
• Interpretation of IST and CAST stroke trials. International Stroke Trial. Chinese Acute Stroke Trial.

  1997cited by this paper
• Interpretation of IST and CAST stroke trials. International Stroke Trial. Chinese Acute Stroke Trial.

  1997cited by this paper
• Aspirin or heparin immediately after a stroke?

  1997cited by this paper
• Interpretation of IST and CAST stroke trials. International Stroke Trial. Chinese Acute Stroke Trial.

  1997cited by this paper
• Lipid metabolism and APC: implications for colorectal cancer prevention.

  1997cited by this paper
• The International Stroke Trial (IST): a randomised trial of aspirin, subcutaneous heparin, both, or neither among 19435 patients with acute ischaemic stroke. International Stroke Trial Collaborative Group.

  1997cited by this paper
• Interpretation of IST and CAST stroke trials

  1997cited by this paper
• Interpretation of IST and CAST stroke trials

  1997cited by this paper
• Windows of the sole

  1997cited by this paper
• Interpretation of IST and CAST stroke trials

  1997cited by this paper
• Interpretation of IST and CAST stroke trials. International Stroke Trial. Chinese Acute Stroke Trial.

  1997cited by this paper
• CAST: randomised placebo-controlled trial of early aspirin use in 20 000 patients with acute ischaemic stroke

  1997cited by this paper
• CAST: randomised placebo-controlled trial of early aspirin use in 20,000 patients with acute ischaemic stroke. CAST (Chinese Acute Stroke Trial) Collaborative Group.

  1997cited by this paper
• The International Stroke Trial (IST): A randomised trial of aspirin, subcutaneous heparin, both, or neither among 19 435 patients with acute ischaemic stroke

  1997cited by this paper
• RANDOMIZED CONTROLLED TRIAL OF STREPTOKINASE, ASPIRIN, AND COMBINATION OF BOTH IN TREATMENT OF ACUTE ISCHEMIC STROKE

  1995cited by this paper
• Randomised controlled trial of streptokinase, aspirin, and combination of both in treatment of acute ischaemic stroke. Multicentre Acute Stroke Trial--Italy (MAST-I) Group.

  1995cited by this paper
• Percutaneous implantation of autologous vein graft stent for treatment of coronary artery disease.

  1995cited by this paper
• Collaborative overview of randomised trials of antiplatelet therapy--I: Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. Antiplatelet Trialists' Collaboration.

  1994cited by this paper
• Collaborative overview of randomised trials of antiplatelet therapy Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients

  1994cited by this paper
• Secondary prevention in non-rheumatic atrial fibrillation after transient ischaemic attack or minor stroke

  1993cited by this paper
• RANDOMISED TRIAL OF INTRAVENOUS STREPTOKINASE, ORAL ASPIRIN, BOTH, OR NEITHER AMONG 17 187 CASES OF SUSPECTED ACUTE MYOCARDIAL INFARCTION: ISIS-2

  1988cited by this paper
• Randomised trial of intravenous streptokinase, oral aspirin, both, or neither among 17,187 cases of suspected acute myocardial infarction: ISIS-2. ISIS-2 (Second International Study of Infarct Survival) Collaborative Group.

  1988cited by this paper
• Cerebrovascular disease in the People's Republic of China

  1985cited by this paper
• Incidence of stroke in Oxfordshire: first year's experience of a community stroke register.

  1983cited by this paper
• Letter: HL-A and infective sacroileitis.

  1974cited by this paper

• Immunotherapies for Ischemic Stroke Patients: Current Status and Future Directions

  2026cites this paper
• Integrative molecular simulations reveal NeuroAid II mechanisms in ischemic stroke through network pharmacology, molecular dynamics, and pharmacophore modeling

  2026cites this paper
• Dilemmas in Secondary Stroke Prevention.

  2025cites this paper
• Thrombolysis With Tenecteplase for Minor Disabling Stroke: Secondary Analysis of the TEMPO-2 Randomized Clinical Trial.

  2025cites this paper
• [Early antithrombotic protection of the brain in patients with ischemic stroke].

  2025cites this paper
• Association between adherence to antiplatelet therapy and the development of recurrent non-cardioembolic ischemic stroke

  2025cites this paper
• Prevalence of Antiplatelet and Anticoagulation Therapy in Children with Sickle Cell Anemia and Stroke.

  2025cites this paper
• Antiplatelet Use Prior to Anticoagulant Initiation in Patients With Atrial Fibrillation-Related Ischemic Stroke: An ELAN Trial Analysis

  2025cites this paper
• Association of perioperative P2Y12 inhibitor administration with outcomes for tandem occlusion: RESCUE AT-LVO sub-study

  2024cites this paper
• Brain-Derived Neurotrophic Factor-TrkB Pathway on Synaptic Plasticity in Ischemic Stroke Rats.

  2024cites this paper
• Efficacy of a melatonin receptor agonist and orexin receptor antagonists in preventing delirium symptoms in the olderly patients with stroke: a retrospective study

  2024cites this paper
• Polymeric nanocarriers delivery systems in ischemic stroke for targeted therapeutic strategies

  2024cites this paper
• Study protocol of the ASTOP trial: A multicenter, randomized, double-blind, placebo-controlled trial of presurgical aspirin administration for the prevention of thromboembolic complications of coil embolization for ruptured aneurysms

  2024cites this paper
• Contemporary Management of Acute Ischemic Stroke.

  2024cites this paper
• The pharmacology of antiplatelet agents for primary, secondary, and tertiary prevention of ischemic stroke

  2024cites this paper
• Frailty in stroke

  2024cites this paper
• Stroke in old age

  2024cites this paper
• Long term outcomes of intracarotid arterial transfusion of circulatory-derived autologous CD34 + cells for acute ischemic stroke patients—A randomized, open-label, controlled phase II clinical trial

  2024cites this paper
• Observation of the Therapeutic Effect of Dual Antiplatelet Therapy with Aspirin and Clopidogrel on the Incidence, Characteristics, and Outcome in Acute Ischemic Stroke Patients with Cerebral Microbleeds at a Teaching Hospital, China

  2024cites this paper
• Selective Inhibition of P2Y1 and P2Y12 Receptor Signal Pathways in Platelet Aggregation in Transgenic Cell Lines and Rats by Potassium 2‐(1‐Hydroxypentyl)‐Benzoate, Puerarin and Salvianolic Acid B

  2024cites this paper
• Prävention des ischämischen Schlaganfalls im Alter

  2024cites this paper
• Clinical Applications of Dual‐Energy Computed Tomography for Acute Ischemic Stroke

  2024cites this paper
• The debatable role of aspirin as a primary prophylactic drug for coronary artery disease: A review

  2023cites this paper
• Risk of secondary stroke subsequent to restarting aspirin in chronic stroke patients suffering from traumatic brain injury in Taiwan

  2023cites this paper
• Human umbilical cord derived mesenchymal stem cells overexpressing HO‐1 attenuate neural injury and enhance functional recovery by inhibiting inflammation in stroke mice

  2023cites this paper
• Efficacy and safety of aspirin antiplatelet therapy within 48 h of symptom onset in patients with acute stroke

  2023cites this paper
• Antithrombotic Therapy for Primary and Secondary Prevention of Ischemic Stroke: JACC State-of-the-Art Review.

  2023cites this paper
• Monitoring risk and preventing ischemic stroke in the very old

  2023cites this paper
• Antiplatelet Use in Ischemic Stroke

  2022cites this paper
• 2022 Update of the Korean Clinical Practice Guidelines for Stroke: Antithrombotic Therapy for Patients with Acute Ischemic Stroke or Transient Ischemic Attack

  2022cites this paper
• Stroke outcome of early antiplatelet in post-thrombolysis haemorrhagic infarction

  2022cites this paper
• Antiplatelet therapy after noncardioembolic ischemic stroke or transient ischemic attack

  2022cites this paper
• Advances of nano drug delivery system for the theranostics of ischemic stroke

  2022cites this paper
• Therapeutic hypothermia for stroke: Unique challenges at the bedside

  2022cites this paper
• Strokelore: Antithrombotic therapy and hemorrhagic infarction.

  2022cites this paper
• Navigating Antiplatelet Treatment Options for Stroke: Evidence-Based and Pragmatic Strategies

  2022cites this paper
• Association of Proton Pump Inhibitor Prophylaxis on Clinical Outcome in Acute Ischemic Stroke in China: A Multicenter Retrospective Cohort Study

  2022cites this paper
• Oral antiplatelet therapy for acute ischaemic stroke.

  2022cites this paper
• Nanotechnology Assisted Biomarker Analysis to Rehabilitate Acute Ischemic Stroke Patients by Early Detection

  2022cites this paper
• Effect of aspirin on cholesterol crystallization: A potential mechanism for plaque stabilization

  2022cites this paper
• High on‐treatment platelet reactivity is associated with poor outcomes after ischemic stroke: A meta‐analysis

  2022cites this paper
• Inpatient Management of Acute Stroke of Unknown Type in Resource-Limited Settings

  2022cites this paper
• [Management of ischemic stroke in the acute phase].

  2021cites this paper
• Serum GFAP for stroke diagnosis in regions with limited access to brain imaging (BE FAST India)

  2021cites this paper
• Uso de Antiplaquetarios en Infarto Cerebral

  2021cites this paper
• Considerations for use of direct oral anticoagulants in arterial disease

  2021cites this paper
• Network Mapping of Time to Antithrombotic Therapy Among Patients With Ischemic Stroke and Transient Ischemic Attack (TIA)

  2021cites this paper
• Oral Antiplatelet Therapy for Secondary Prevention of Non-Cardioembolic Ischemic Cerebrovascular Events

  2021cites this paper
• Effect of antiplatelet persistence on long-term mortality and predictors of non-persistence in ischemic stroke patients 75 years and older: a nationwide cohort study

  2021cites this paper
• Age is just a number: the concept of time to benefit in older adults

  2021cites this paper
• Short-term outcomes of Chinese transient ischaemic attack patients in an Emergency department in Hong Kong: Result of management with an agreed protocol with neurologists

  2021cites this paper
• Synergic effect of combined cyclosporin and melatonin protects the brain against acute ischemic reperfusion injury.

  2021cites this paper
• Acute Stroke Biomarkers: Are We There Yet?

  2021cites this paper
• Aspirin as a Potential Geroprotector: Experimental Data and Clinical Evidence.

  2021cites this paper
• Prevalence of delayed diagnosis of acute ischemic stroke in an acute care hospital: A single‐center cross‐sectional study in Japan

  2021cites this paper
• In the THALES Trial, Past, Present, and Future Meet

  2021cites this paper
• FACTORS ASSOCIATED WITH ORAL INTAKE ABILITY IN PATIENTS WITH ACUTE-STAGE STROKE

  2021cites this paper
• Evaluating Treatment Prioritization Rules via Rank-Weighted Average Treatment Effects

  2021cites this paper
• Antithrombotic Therapy in the Prevention of Stroke

  2021cites this paper
• European Stroke Organisation (ESO) guidelines on management of transient ischaemic attack

  2021cites this paper
• Interdisziplinäre Aspekte der oralen Antikoagulation mit NOAKs bei Vorhofflimmern

  2021cites this paper
• Counterfactual Clinical Prediction Models Could help to Infer Individualised Treatment Effects in Randomised Controlled Trials - an Illustration with the International Stroke Trial.

  2020cites this paper
• Intra-carotid arterial transfusion of circulatory-derived autologous endothelial progenitor cells in rodent after ischemic stroke—evaluating the impact of therapeutic time points on prognostic outcomes

  2020cites this paper
• Effects of antiplatelet therapy on stroke risk by brain imaging features of intracerebral haemorrhage and cerebral small vessel diseases: subgroup analyses of the RESTART randomised, open­label trial

  2020cites this paper
• Challenges of delivering evidence-based stroke services for rural areas in Australia.

  2020cites this paper
• Stroke.

  2020cites this paper
• Antithrombotic therapy in patients with recent stroke and atrial fibrillation.

  2020cites this paper
• Neurological deterioration and its risk score in total anterior circulation infarct.

  2020cites this paper
• Multiple versus fewer antiplatelet agents for preventing early recurrence after ischaemic stroke or transient ischaemic attack.

  2020cites this paper
• Acute Ischemic Stroke.

  2020cites this paper
• Neurocritical Care in Resource-limited Settings.

  2020cites this paper
• Role of the Platelets and Nitric Oxide Biotransformation in Ischemic Stroke: A Translative Review from Bench to Bedside

  2020cites this paper
• Clinical Features, Risk Factors and Hospital Mortality of Acute Stroke Patients

  2020cites this paper
• Intra-carotid arterial transfusion of circulatory-derived autologous CD34+ cells in rodent after ischemic stroke — evaluate the impact of therapeutic time points on prognostic outcomes

  2020cites this paper
• Stroke syndromes

  2020cites this paper
• Management of Acute Ischemic Stroke

  2020cites this paper
• Antiplatelet Therapy

  2020cites this paper
• The Value of SNACC Membership: A Past President's Perspective.

  2020cites this paper
• 脳神経外科医が知るべき抗血栓療法のリスク・ベネフィット・適応

  2019cites this paper
• Specific treatment of acute ischemic stroke

  2019cites this paper
• Preventing recurrent stroke and other serious vascular events

  2019cites this paper
• Antiplatelet Drugs in the Management of Cerebral Ischemia

  2019cites this paper
• Clinical efficacy of aspirin combined with clopidogrel in treating cerebral infarction and its effect on serum hs-CRP, sICAM-1 and TNF-α

  2019cites this paper
• Edinburgh Research Explorer Effects of antiplatelet therapy on stroke risk by brain imaging features of intracerebral haemorrhage and cerebral small vessel diseases

  2019cites this paper
• Stroke in the elderly.

  2019cites this paper
• Advances in stroke medicine

  2019cites this paper
• Association Between ABCB1 Polymorphisms and Outcomes of Clopidogrel Treatment in Patients With Minor Stroke or Transient Ischemic Attack: Secondary Analysis of a Randomized Clinical Trial

  2019cites this paper
• Timing of Initiation of Oral Anticoagulation after Acute Ischemic Stroke in Patients with Atrial Fibrillation

  2019cites this paper
• LSHTM Research Online

  2019cites this paper
• Stroke and transient ischaemic attack in over 16s: diagnosis and initial management

  2019cites this paper
• Risk Stratification and Management of TIA and Minor Stroke

  2019cites this paper
• Hematologic Interventions for Acute Central Nervous System Disease

  2019cites this paper
• Anticoagulation Resumption After Stroke from Atrial Fibrillation

  2019cites this paper
• Transient Ischemic Attack

  2019cites this paper
• Therapeutic Aspects of Nanomedicines in Stroke Treatment

  2019cites this paper
• Effects of antiplatelet therapy on stroke risk by brain imaging features of intracerebral haemorrhage and cerebral small vessel diseases: subgroup analyses of the RESTART randomised, open-label trial

  2019cites this paper
• Aspirin in stroke patients modifies the immunomodulatory interactions of marrow stromal cells and monocytes.

  2019cites this paper
• Antithrombotic treatment for secondary prevention of stroke and other thromboembolic events in patients with stroke or transient ischemic attack and non-valvular atrial fibrillation: A European Stroke Organisation guideline

  2019cites this paper
• MANAGEMENT OF ANTITHROMBOTIC THERAPY IN PATIENTS WITH STROKE: WHERE DO WE STAND IN 2018?

  2019cites this paper
• Prevention and Treatment of Acute Stroke in the Nonagenarians and Beyond: Medical and Ethical Issues

  2019cites this paper